Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Shares Outstanding: 2022-2025

Historic Shares Outstanding for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $55.1 million.

  • Stoke Therapeutics' Shares Outstanding rose 4.12% to $55.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 4.12%. This contributed to the annual value of $54.0 million for FY2024, which is 17.67% up from last year.
  • As of Q3 2025, Stoke Therapeutics' Shares Outstanding stood at $55.1 million, which was up 0.72% from $54.7 million recorded in Q2 2025.
  • Stoke Therapeutics' 5-year Shares Outstanding high stood at $55.1 million for Q3 2025, and its period low was $39.0 million during Q1 2022.
  • Over the past 3 years, Stoke Therapeutics' median Shares Outstanding value was $52.3 million (recorded in 2024), while the average stood at $49.9 million.
  • Data for Stoke Therapeutics' Shares Outstanding shows a peak YoY grew of 19.52% (in 2024) over the last 5 years.
  • Stoke Therapeutics' Shares Outstanding (Quarterly) stood at $39.4 million in 2022, then grew by 16.43% to $45.9 million in 2023, then grew by 17.67% to $54.0 million in 2024, then climbed by 4.12% to $55.1 million in 2025.
  • Its Shares Outstanding stands at $55.1 million for Q3 2025, versus $54.7 million for Q2 2025 and $54.6 million for Q1 2025.